These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30604896)

  • 1. GRB7 dependent proliferation of basal-like, HER-2 positive human breast cancer cell lines is mediated in part by HER-1 signaling.
    Luoh SW; Wagoner W; Wang X; Hu Z; Lai X; Chin K; Sears R; Ramsey E
    Mol Carcinog; 2019 May; 58(5):699-707. PubMed ID: 30604896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of Akt-mediated gene repression.
    Nencioni A; Cea M; Garuti A; Passalacqua M; Raffaghello L; Soncini D; Moran E; Zoppoli G; Pistoia V; Patrone F; Ballestrero A
    PLoS One; 2010 Feb; 5(2):e9024. PubMed ID: 20126311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGF-induced Grb7 recruits and promotes Ras activity essential for the tumorigenicity of Sk-Br3 breast cancer cells.
    Chu PY; Li TK; Ding ST; Lai IR; Shen TL
    J Biol Chem; 2010 Sep; 285(38):29279-85. PubMed ID: 20622016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GRB7 is an oncogenic driver and potential therapeutic target in oesophageal adenocarcinoma.
    Gotovac JR; Liu DS; Yates MJ; Milne JV; Macpherson AA; Simpson KJ; Eslick GD; Mitchell C; Duong CP; Phillips WA; Clemons NJ
    J Pathol; 2020 Nov; 252(3):317-329. PubMed ID: 32737994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TCF12-regulated GRB7 facilitates the HER2+ breast cancer progression by activating Notch1 signaling pathway.
    Wang G; Wu Y; Su Y; Qu N; Chen B; Zhou D; Yuan L; Yin M; Liu M; Zhou W
    J Transl Med; 2024 Aug; 22(1):745. PubMed ID: 39113057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation.
    Bai T; Luoh SW
    Carcinogenesis; 2008 Mar; 29(3):473-9. PubMed ID: 17916906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GRB7 protein over-expression and clinical outcome in breast cancer.
    Ramsey B; Bai T; Hanlon Newell A; Troxell M; Park B; Olson S; Keenan E; Luoh SW
    Breast Cancer Res Treat; 2011 Jun; 127(3):659-69. PubMed ID: 20635137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GRB7 is required for triple-negative breast cancer cell invasion and survival.
    Giricz O; Calvo V; Pero SC; Krag DN; Sparano JA; Kenny PA
    Breast Cancer Res Treat; 2012 Jun; 133(2):607-15. PubMed ID: 22005836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting GRB7/ERK/FOXM1 signaling pathway impairs aggressiveness of ovarian cancer cells.
    Chan DW; Hui WW; Cai PC; Liu MX; Yung MM; Mak CS; Leung TH; Chan KK; Ngan HY
    PLoS One; 2012; 7(12):e52578. PubMed ID: 23285101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGFR signaling promotes the growth of triple-negative and basal-like breast cancer cell lines both in vitro and in vivo.
    Sharpe R; Pearson A; Herrera-Abreu MT; Johnson D; Mackay A; Welti JC; Natrajan R; Reynolds AR; Reis-Filho JS; Ashworth A; Turner NC
    Clin Cancer Res; 2011 Aug; 17(16):5275-86. PubMed ID: 21712446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. circCDYL2 promotes trastuzumab resistance via sustaining HER2 downstream signaling in breast cancer.
    Ling Y; Liang G; Lin Q; Fang X; Luo Q; Cen Y; Mehrpour M; Hamai A; Liu Z; Shi Y; Li J; Lin W; Jia S; Yang W; Liu Q; Song E; Li J; Gong C
    Mol Cancer; 2022 Jan; 21(1):8. PubMed ID: 34980129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Knockdown of Grb7 inhibits growth of oral squamous cell carcinoma, cell proliferation and promoted apoptosis through ERK/FOXM1 pathway].
    Liu BY; Cao G; Dong Z; Chen W; Xu JK; Zhang SL; Weng ZQ
    Shanghai Kou Qiang Yi Xue; 2016 Dec; 25(6):688-693. PubMed ID: 28275791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer.
    Nadler Y; González AM; Camp RL; Rimm DL; Kluger HM; Kluger Y
    Ann Oncol; 2010 Mar; 21(3):466-473. PubMed ID: 19717535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulated GRB7 promotes proliferation and tumorigenesis of Bladder Cancer via Phospho-AKT Pathway.
    Zheng Y; Pei Y; Yang L; Zeng Z; Wang J; Xie G; Wang L; Yuan J
    Int J Biol Sci; 2020; 16(16):3221-3230. PubMed ID: 33162827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis.
    Tanaka S; Pero SC; Taguchi K; Shimada M; Mori M; Krag DN; Arii S
    J Natl Cancer Inst; 2006 Apr; 98(7):491-8. PubMed ID: 16595785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the calmodulin-regulated ErbB/Grb7 signaling axis in cancer therapy.
    Villalobo A; García-Palmero I; Stateva SR; Jellali K
    J Pharm Pharm Sci; 2013; 16(2):177-89. PubMed ID: 23958188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic interaction between trastuzumab and EGFR/HER-2 tyrosine kinase inhibitors in HER-2 positive breast cancer cells.
    O'Donovan N; Byrne AT; O'Connor AE; McGee S; Gallagher WM; Crown J
    Invest New Drugs; 2011 Oct; 29(5):752-9. PubMed ID: 20229355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive NOTCH3 Signaling Promotes the Growth of Basal Breast Cancers.
    Choy L; Hagenbeek TJ; Solon M; French D; Finkle D; Shelton A; Venook R; Brauer MJ; Siebel CW
    Cancer Res; 2017 Mar; 77(6):1439-1452. PubMed ID: 28108512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells.
    Hochgräfe F; Zhang L; O'Toole SA; Browne BC; Pinese M; Porta Cubas A; Lehrbach GM; Croucher DR; Rickwood D; Boulghourjian A; Shearer R; Nair R; Swarbrick A; Faratian D; Mullen P; Harrison DJ; Biankin AV; Sutherland RL; Raftery MJ; Daly RJ
    Cancer Res; 2010 Nov; 70(22):9391-401. PubMed ID: 20861192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Context-dependent role of Grb7 in HER2+ve and triple-negative breast cancer cell lines.
    Lim RC; Price JT; Wilce JA
    Breast Cancer Res Treat; 2014 Feb; 143(3):593-603. PubMed ID: 24464577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.